Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,415.00+0.36%ETH$2,246.32+1.22%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
West Pharmaceutical Services, Inc. logo

NYSE · WST

West Pharmaceutical Services, Inc.

Healthcare · Medical - Instruments & Supplies

$416.67

Down-$4.05 (-0.97%)

Updated Oct 31, 2026, 1:39 AM

SID Score

6.9/10

Composite research score

Smart Money

58/100

Neutral

Market cap
19.61B
P/E ratio
40.07
Dividend yield
0.26%
52-week range
$223.83 – $438.27
Volume
1.87M
Avg. volume
696.99K

Price performance · WST

WST price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 29, 2026

WST closed at $416.67 after 20 trading sessions, up 14.16% for the selected period.

Last close
$416.67
Period change
+14.16%
Period low
$363.27
Period high
$416.67
Daily close
View OHLC price history
WST OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 29, 2026$420.69$438.27$415.32$416.671.87M
Oct 28, 2026$396.95$404.985$396.83$403.64773.29K
Oct 27, 2026$392.90$398.67$391.78$398.29790.69K
Oct 26, 2026$389.80$395.28$388.06$394.73649.66K
Oct 23, 2026$391.60$394.175$389.72$392.15718.05K
Oct 22, 2026$394.15$397.155$389.17$394.03679.94K
Oct 21, 2026$381.98$396.00$381.98$393.48573.85K
Oct 20, 2026$387.54$389.75$384.21$388.78569.98K
Oct 19, 2026$383.78$387.0132$383.20$383.91312.78K
Oct 16, 2026$382.74$386.26$380.28$384.02511.19K
Oct 15, 2026$377.00$384.40$376.10$383.02390.45K
Oct 14, 2026$372.21$379.21$372.21$374.65444.57K
Oct 13, 2026$369.54$378.84$367.50$371.82507.58K
Oct 12, 2026$366.72$371.755$363.0983$367.60357.33K
Oct 9, 2026$363.31$370.20$362.175$366.00480.22K
Oct 8, 2026$365.65$367.25$359.4886$363.27461.7K
Oct 7, 2026$371.66$374.79$365.345$366.48438.04K
Oct 6, 2026$379.02$381.16$367.635$372.64401.4K
Oct 5, 2026$364.69$377.06$363.16$376.76682.77K
Oct 2, 2026$364.74$368.8538$363.26$364.98473.02K

Latest WST news

The latest Smart Investors Daily articles mentioning WST.

Stock researchCompany · Overview

WST research

Overview

Company profile and research snapshot.

Company profile

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$335.17
Implied upside
—
Analysts
—
WST recent ratings
DateFirmRatingTarget
Oct 13, 2026TD CowenBuy—
Oct 7, 2026BarclaysOverweight—
Sep 22, 2026Morgan StanleyOverweight—
Sep 9, 2026UBSBuy—
Aug 3, 2026CitigroupBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 19, 2026

West Declares Quarterly Dividend

On October 19, 2026, the Board of Directors of West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared a fourth-quarter dividend of $0.26 per share on the Company's common stock, an 18% increase over the $0.22 per share paid in the prior quarter. This is the thirty-fourth consecutive annual increase in the Company's dividend. The dividend is payable on November 18, 2026, to shareholders of record on November 11, 2026.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By